PTPRC and leukemia: As shown in Figure 3, treatment with 10 mg/kg IgG1 C47B157, C47B161 and C47B222 potently suppressed leukemia outgrowth (0.74–2.78% CD45+ cells) across all models vs PBS control treated mice (23.2–88.5% CD45+ cells).